Companies / ALX Oncology
ALX Oncology
South San Francisco, United States
ALX Oncology is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives.
ALX Oncology, based in South San Francisco, United States, has 3 investors on file, among them Foresite Capital, Lightstone Ventures and venBio. Its site was last checked 13 Nov 2026: site answers.
Investors
3 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
In the news
1 headline naming ALX OncologyEach headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get ALX Oncology and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Foresite Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/alxoncology.com/investors
# also
GET /v1/companies/alxoncology.com
GET /v1/companies/alxoncology.com/news